Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-89 |
Sentence |
denotes |
PIK3R3 regulates ZO-1 expression through the NF-kB pathway in inflammatory bowel disease. |
T2 |
90-110 |
Sentence |
denotes |
BACKGROUND AND AIMS: |
T3 |
111-217 |
Sentence |
denotes |
Inflammatory bowel disease (IBD) are the major risk factor for developing colitis associated cancer (CAC). |
T4 |
218-398 |
Sentence |
denotes |
Previously, we have reported that Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3) was overexpressed in colorectal cancer (CRC), but we don't know the role of PIK3R3 in IBD. |
T5 |
399-407 |
Sentence |
denotes |
METHODS: |
T6 |
408-574 |
Sentence |
denotes |
We investigated the differential expression of PIK3R3 and ZO-1 in IBD patients by using Immunohistochemical (IHC) and Gene Expression Omnibus (GEO) database analysis. |
T7 |
575-676 |
Sentence |
denotes |
Caco-2 cells were exposed to different conditions to assess protein level changes of PIK3R3 and ZO-1. |
T8 |
677-786 |
Sentence |
denotes |
Caco-2 cell monolayers were transfected with PIK3R3/siPIK3R3 to assess transepithelial electrical resistance. |
T9 |
787-870 |
Sentence |
denotes |
Tight junction protein integrity was assessed by immunoblot and immunofluorescence. |
T10 |
871-1048 |
Sentence |
denotes |
For further, intestinal permeability and tight junction protein integrity were assessed in animal study to assess the treatment role of PIK3R3 specific inhibitor TAT-N 15 (N15). |
T11 |
1049-1145 |
Sentence |
denotes |
RESULTS: PIK3R3 was increased in IBD patients, and negatively controlled the expression of ZO-1. |
T12 |
1146-1206 |
Sentence |
denotes |
In vitro, PIK3R3 regulates ZO-1 by activating NF-kB pathway. |
T13 |
1207-1354 |
Sentence |
denotes |
Overexpression of PIK3R3 in Caco-2 cells decreased transepithelial electrical resistance (TEER), an opposite result was observed in siPIK3R3 cells. |
T14 |
1355-1467 |
Sentence |
denotes |
In animal study, inhibition of PIK3R3 by N15 contributed to amelioration of DSS-induced intestinal permeability. |
T15 |
1468-1540 |
Sentence |
denotes |
Mice treated with N15 exhibited less disruption of TJs in colon tissues. |
T16 |
1541-1648 |
Sentence |
denotes |
CONCLUSIONS: PIK3R3 was increased in clinical IBD patients with accompanying disruption of ZO-1 expression. |
T17 |
1649-1723 |
Sentence |
denotes |
Inhibition of PIK3R3 attenuated DSS-induced IBD symptoms in a mouse model. |
T18 |
1724-1799 |
Sentence |
denotes |
These findings indicated that PIK3R3 could be a therapeutic target for IBD. |
T1 |
0-89 |
Sentence |
denotes |
PIK3R3 regulates ZO-1 expression through the NF-kB pathway in inflammatory bowel disease. |
T2 |
90-110 |
Sentence |
denotes |
BACKGROUND AND AIMS: |
T3 |
111-217 |
Sentence |
denotes |
Inflammatory bowel disease (IBD) are the major risk factor for developing colitis associated cancer (CAC). |
T4 |
218-398 |
Sentence |
denotes |
Previously, we have reported that Phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3) was overexpressed in colorectal cancer (CRC), but we don't know the role of PIK3R3 in IBD. |
T5 |
399-407 |
Sentence |
denotes |
METHODS: |
T6 |
408-574 |
Sentence |
denotes |
We investigated the differential expression of PIK3R3 and ZO-1 in IBD patients by using Immunohistochemical (IHC) and Gene Expression Omnibus (GEO) database analysis. |
T7 |
575-676 |
Sentence |
denotes |
Caco-2 cells were exposed to different conditions to assess protein level changes of PIK3R3 and ZO-1. |
T8 |
677-786 |
Sentence |
denotes |
Caco-2 cell monolayers were transfected with PIK3R3/siPIK3R3 to assess transepithelial electrical resistance. |
T9 |
787-870 |
Sentence |
denotes |
Tight junction protein integrity was assessed by immunoblot and immunofluorescence. |
T10 |
871-1048 |
Sentence |
denotes |
For further, intestinal permeability and tight junction protein integrity were assessed in animal study to assess the treatment role of PIK3R3 specific inhibitor TAT-N 15 (N15). |
T11 |
1049-1145 |
Sentence |
denotes |
RESULTS: PIK3R3 was increased in IBD patients, and negatively controlled the expression of ZO-1. |
T12 |
1146-1206 |
Sentence |
denotes |
In vitro, PIK3R3 regulates ZO-1 by activating NF-kB pathway. |
T13 |
1207-1354 |
Sentence |
denotes |
Overexpression of PIK3R3 in Caco-2 cells decreased transepithelial electrical resistance (TEER), an opposite result was observed in siPIK3R3 cells. |
T14 |
1355-1467 |
Sentence |
denotes |
In animal study, inhibition of PIK3R3 by N15 contributed to amelioration of DSS-induced intestinal permeability. |
T15 |
1468-1540 |
Sentence |
denotes |
Mice treated with N15 exhibited less disruption of TJs in colon tissues. |
T16 |
1541-1648 |
Sentence |
denotes |
CONCLUSIONS: PIK3R3 was increased in clinical IBD patients with accompanying disruption of ZO-1 expression. |
T17 |
1649-1723 |
Sentence |
denotes |
Inhibition of PIK3R3 attenuated DSS-induced IBD symptoms in a mouse model. |
T18 |
1724-1799 |
Sentence |
denotes |
These findings indicated that PIK3R3 could be a therapeutic target for IBD. |